| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 10,800 | $40 | $410.4K |
| J0897 | Injection, denosumab, 1 mg | 6,600 | $20 | $125.4K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 3,300 | $20 | $56.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 440 | $100 | $43.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 580 | $70 | $42.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 250 | $110 | $27.8K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 300 | $90 | $25.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 120 | $180 | $21.1K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,220 | $1 | $18.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 120 | $150 | $17.5K |